false
OasisLMS
Login
Skip Navigation Links
Publications
JTO
CRR
ILCN
Menu
Publications
JTO
CRR
ILCN
Hamburger Menu
Catalog
VIKTOR
Catalog
ESMO 2026 Highlights – Part 2
ESMO 2026 Highlights – Part 2
Podcast | English | 2026 | 60 Min
Create Account
Cost
$0.00
Credit
No Credit Offered
IASLC Lung Cancer Considered Podcast
In Part 2 of our ESMO 2026 Highlights series, Dr. Stephen Liu and Dr. Narjust Florez welcome Dr. Xiao-Rong Dong, Dr. Yi-Long Wu, and Dr. Chantal Decroisette to discuss three important clinical trials: SAFFRON, SANOVO, and PERSEE. The conversations explore emerging strategies for targeting MET in EGFR-mutated non-small cell lung cancer, advances in first-line immunotherapy, and the potential implications of these findings for clinical practice.
×
ESMO 2026 Highlights – Part 2 Course List
Login
×
Please select your language
1
English